Archives: Agenda
Lunch and networking
Prize Draw taking place in exhibition hall at 14:15
Join us for a chance to win one of our prizes, including Apple products
PANEL DISCUSSION: Turning Transit Troubles into Triumphs: Proven Strategies for Clinical Supply Success
- Common causes of transit issues: shipment delays, temperature excursions, customs holds, and packaging failures
- Addressing gaps in global regulatory guidance
- Practical solutions for streamlining supply chain processes
Why do clinical supply also require shipping validation
- Overview of recent changes in regional regulations.
- Supplier management
- Shipping validation case study
Morning refreshments and networking
From Lab to Lift-Off: Ensuring Compliance with IATA TCR for Clinical Trial Shipments
- Market Outlook
- IATA Standards Setting & TCR Regulations
- IATA Pharma Solutions
Streamlining the End-to-End pharmaceutical supply Chain: Enhancing efficiency and quality
- Understanding the complexities and challenges of the end-to-end pharmaceutical supply chain, from manufacturing to patient delivery
- Addressing regulatory requirements and compliance
- How did we implement effective strategies to enhance the end-to-end pharmaceutical supply chain
Clinical Trials Surge in 2025
- In H1, trial initiations significantly increased in comparison to previous years
- Explore the latest trial trends, challenges, and opportunities for suppliers shaping clinical trials this year
- See how this has shaken up the biopharma competitive landscape and how this will affect the clinical trial supply chain
Chairperson’s opening remarks
Shifting Paradigms in the Treatment of Alzheimer’s Disease: AriBio and the Emergence of Korea’s First Global Blockbuster Candidate, AR1001
- This presentation explores how AR1001 is poised to redefine the Alzheimer’s disease (AD) treatment landscape as a first-in-class, oral, disease-modifying therapy — bringing fresh momentum to a field that has seen limited progress over the past two decades
- We will delve into the scientific breakthroughs and strategic learnings gained through years of innovation and perseverance within the highly challenging global AD space
- Finally, we spotlight AriBio’s commitment to delivering the right therapy to the right patients at the right time, while upholding rigorous global regulatory and quality standards to support successful approvals in both the U.S. (FDA) and Europe (EMA)